Search results
examples of biohazardous waste • Microbiological cultures or stocks (including bacterial, viral, parasitic, fungal, etc.) • Recombinant or synthetic nucleic acid molecules (including viral vectors)
20 lut 2024 · Regardless of the type, biohazardous waste must be: 1. collected in a biohazard-labeled container designed to prevent contact with and accidental release of the waste; and 2. rendered nonhazardous prior to disposal by a method suitable for the waste type.
Biohazardous waste includes research-related wastes that are contaminated with recombinant or synthetic nucleic acids, agents infectious to humans, animals or plants, or fluids that may contain these contaminants.
Human activities produce biological waste in the form of human excreta or other discarded materials, much of which may contain infectious microorganisms. Such waste, if untreated, has varying degrees of potential to cause disease.
This Guideline is developed to assist personnel, who utilize microbiological laboratories at the Boston University Medical Campus (“BUMC”), in the proper disposal of biological waste generated by their operations. This Guideline establishes the minimum requirements for RG1 and RG2 biological waste management in BSL1and BSL2 laboratories.
Biological waste is defined as the disposal of any non-human disease agent or equipment that has come in contact with the non-human disease agent. Examples of biological waste are general zoonotic vectors used in research and cultures used in plant pathology research.
Biohazardous waste must be treated prior to disposal. Most often this involves on-site autoclaving. In some cases, chemical disinfection may be appropriate. When neither of these options are feasible or appropriate, biowaste may be sent to an off-site vendor for treatment and disposal.
